[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 4115 Engrossed in Senate (ES)]
109th CONGRESS
2d Session
S. 4115
_______________________________________________________________________
AN ACT
To amend the Controlled Substances Act to increase the effectiveness of
physician assistance for drug treatment.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Effective Physician Assistance for
Drug Treatment Act''.
SEC. 2. CONTROLLED SUBSTANCES ACT AMENDMENTS.
Section 303(g)(2) of the Controlled Substances Act (21 U.S.C.
823(g)(2)) is amended--
(1) in subparagraph (B)(iii), by striking ``except that
the'' and inserting the following: ``unless, not sooner than 1
year after the date on which the practitioner submitted the
initial notification, the practitioner submits a second
notification to the Secretary of the need and intent of the
practitioner to treat up to 100 patients. A second notification
under this clause shall contain the certifications required by
clauses (i) and (ii) of this subparagraph. The''; and
(2) in subparagraph (J)--
(A) in clause (i), by striking ``thereafter'' and
all that follows through the period and inserting
``thereafter.'';
(B) in clause (ii), by striking ``Drug Addiction
Treatment Act of 2000'' and inserting ``Effective
Physician Assistance for Drug Treatment Act''; and
(C) in clause (iii), by striking ``this paragraph
should not remain in effect, this paragraph ceases to
be in effect'' and inserting ``subparagraph (B)(iii)
should be applied by limiting the total number of
patients a practitioner may treat to 30, then the
provisions in such subparagraph (B)(iii) permitting
more than 30 patients shall not apply, effective''.
Passed the Senate December 8, 2006.
Attest:
Secretary.
109th CONGRESS
2d Session
S. 4115
_______________________________________________________________________
AN ACT
To amend the Controlled Substances Act to increase the effectiveness of
physician assistance for drug treatment.